Decentralized and Hybrid Trials

Decentralized Clinical Trials: Bust or Breakthrough?

Applied Clinical Trials met with Troy Astorino, our Co-founder and Chief Technology Officer, to discuss the opportunity that remains within decentralized observational trials. Troy shares his thoughts on where DCT technologies went wrong and what it takes to unlock the potential within virtual and hybrid observational studies. Explore his take in the full article.